|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.55%
|
98.95%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
98.95%
|
99.17%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
98.73%
|
94.66%
|
|
CHEMBL299
|
P17252
|
Protein kinase C alpha |
98.27%
|
98.03%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
97.40%
|
96.85%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
97.17%
|
98.33%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
96.48%
|
96.09%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
96.03%
|
93.56%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
95.63%
|
95.71%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
95.60%
|
90.17%
|
|
CHEMBL4072
|
P07858
|
Cathepsin B |
95.51%
|
93.67%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
95.48%
|
94.45%
|
|
CHEMBL2955
|
O95136
|
Sphingosine 1-phosphate receptor Edg-5 |
95.35%
|
92.86%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
94.82%
|
97.06%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
94.76%
|
96.47%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
94.21%
|
92.38%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
94.09%
|
95.00%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
94.07%
|
97.21%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
93.80%
|
97.29%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
93.75%
|
100.00%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
93.29%
|
91.81%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
93.09%
|
93.10%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
92.91%
|
96.61%
|
|
CHEMBL4769
|
O95749
|
Geranylgeranyl pyrophosphate synthetase |
91.68%
|
92.08%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
90.40%
|
97.50%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
90.22%
|
96.28%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
90.20%
|
100.00%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
89.67%
|
93.00%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
89.47%
|
97.29%
|
|
CHEMBL6136
|
O60341
|
Lysine-specific histone demethylase 1 |
89.06%
|
95.58%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
88.68%
|
97.14%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
88.63%
|
90.71%
|
|
CHEMBL321
|
P14780
|
Matrix metalloproteinase 9 |
88.26%
|
92.12%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
88.20%
|
97.25%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
88.15%
|
100.00%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
88.08%
|
89.50%
|
|
CHEMBL2001
|
Q9H244
|
Purinergic receptor P2Y12 |
88.03%
|
96.00%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
87.86%
|
91.11%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
87.65%
|
100.00%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
87.22%
|
91.19%
|
|
CHEMBL1907602
|
P06493
|
Cyclin-dependent kinase 1/cyclin B1 |
87.07%
|
91.24%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
86.85%
|
96.90%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
86.65%
|
90.08%
|
|
CHEMBL4203
|
Q9HAZ1
|
Dual specificity protein kinase CLK4 |
86.50%
|
94.45%
|
|
CHEMBL325
|
Q13547
|
Histone deacetylase 1 |
86.35%
|
95.92%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
86.28%
|
95.36%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
85.65%
|
97.09%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
85.05%
|
88.42%
|
|
CHEMBL1907605
|
P24864
|
Cyclin-dependent kinase 2/cyclin E1 |
84.81%
|
92.88%
|
|
CHEMBL5255
|
O00206
|
Toll-like receptor 4 |
84.80%
|
92.50%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
84.62%
|
96.00%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
84.61%
|
97.50%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
84.49%
|
95.27%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
84.23%
|
95.17%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
83.81%
|
99.35%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
83.58%
|
98.94%
|
|
CHEMBL5701
|
Q9H2K8
|
Serine/threonine-protein kinase TAO3 |
83.52%
|
96.67%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
83.41%
|
97.47%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
83.40%
|
97.64%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
83.06%
|
94.33%
|
|
CHEMBL256
|
P0DMS8
|
Adenosine A3 receptor |
82.68%
|
95.93%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
82.30%
|
95.89%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
82.13%
|
95.50%
|
|
CHEMBL1801
|
P00747
|
Plasminogen |
81.45%
|
92.44%
|
|
CHEMBL4662
|
P28074
|
Proteasome Macropain subunit MB1 |
81.31%
|
93.85%
|
|
CHEMBL3108638
|
O15164
|
Transcription intermediary factor 1-alpha |
80.95%
|
95.56%
|
|
CHEMBL3004
|
P33527
|
Multidrug resistance-associated protein 1 |
80.62%
|
96.37%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
80.47%
|
97.50%
|